Market Size of Apoptosis Assay Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 9.30 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Apoptosis Assay Market Analysis
The major factors attributing to the growth of the apoptosis assay market are the rising incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others. Rise in population suffering from chronic and autoimmune diseases are propelling the demand for market growth. In 2018, as per the AARDA (AMERICAN AUTOIMMUNE RELATED DISEASE ASSOCIATION) statistics, around 50 million Americans have an autoimmune disease, and this number is expected to rise in the future. And there are few more factors which are playing crucial roles in taking the apoptosis assay market to the next level, among them one is on-going developments related to apoptosis-modulating drugs which are expected to further propel the growth of the global apoptosis assays market. However, Increasing demand for high-content diagnosis and clinical research for cancer, in particular, is indeed bolstering market growth during the forecasted period.